Breast tenderness and breast cancer risk in the estrogen plus progestin and estrogen-alone women’s health initiative clinical trials

[1]  J. Manson,et al.  Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy: a randomized controlled trial. , 2011, JAMA.

[2]  J. Ockene,et al.  Menopausal symptom experience before and after stopping estrogen therapy in the Women's Health Initiative randomized, placebo-controlled trial , 2010, Menopause.

[3]  J. Manson,et al.  Estrogen alone in postmenopausal women and breast cancer detection by means of mammography and breast biopsy. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  C. Y. Wang,et al.  Conjugated equine estrogen influence on mammographic density in postmenopausal women in a substudy of the women's health initiative randomized trial. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  G. Greendale,et al.  Predictors of breast discomfort among women initiating menopausal hormone therapy , 2009, Menopause.

[6]  L. Kuller,et al.  New-onset breast tenderness after initiation of estrogen plus progestin therapy and breast cancer risk. , 2009, Archives of internal medicine.

[7]  Lewis H Kuller,et al.  Benefits and risks of postmenopausal hormone therapy when it is initiated soon after menopause. , 2009, American journal of epidemiology.

[8]  D. Siscovick,et al.  Test-retest reliability of the Women's Health Initiative physical activity questionnaire. , 2009, Medicine and science in sports and exercise.

[9]  T. Meade,et al.  Health related quality of life after combined hormone replacement therapy: randomised controlled trial , 2008, BMJ : British Medical Journal.

[10]  G. Greendale,et al.  Effects of alcohol and cigarette smoking on change in serum estrone levels in postmenopausal women randomly assigned to fixed doses of conjugated equine estrogens with or without a progestin , 2008, Menopause.

[11]  G. Anderson,et al.  Predicting risk of breast cancer in postmenopausal women by hormone receptor status. , 2007, Journal of the National Cancer Institute.

[12]  G. Ursin,et al.  Association of new-onset breast discomfort with an increase in mammographic density during hormone therapy. , 2006, Archives of internal medicine.

[13]  Garnet L Anderson,et al.  Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy. , 2006, JAMA.

[14]  C. Y. Wang,et al.  Estrogen-plus-progestin use and mammographic density in postmenopausal women: Women's Health Initiative randomized trial. , 2005, Journal of the National Cancer Institute.

[15]  S. Carranza-Lira,et al.  Evaluation of mastodynia in postmenopausal women taking hormone therapy , 2005, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[16]  Susan R. Johnson,et al.  Menopausal Symptoms and Treatment-Related Effects of Estrogen and Progestin in the Women's Health Initiative , 2005, Obstetrics and gynecology.

[17]  H. Uemura,et al.  Serum estrogen level after hormone replacement therapy and body mass index in postmenopausal and bilaterally ovariectomized women. , 2005, Maturitas.

[18]  C. Ulrich,et al.  Effect of exercise on serum estrogens in postmenopausal women: a 12-month randomized clinical trial. , 2004, Cancer research.

[19]  James G. Anderson.  Surgical Training, Error , 2004 .

[20]  John Robbins,et al.  National cross sectional survey to determine whether the decision to delivery interval is critical in emergency caesarean section , 2004, BMJ : British Medical Journal.

[21]  R. Langer,et al.  Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial. , 2003, JAMA.

[22]  C. Kooperberg,et al.  Outcomes ascertainment and adjudication methods in the Women's Health Initiative. , 2003, Annals of epidemiology.

[23]  J. Manson,et al.  Walking compared with vigorous exercise for the prevention of cardiovascular events in women. , 2002, The New England journal of medicine.

[24]  W. Hänggi,et al.  Effects of tibolone and continuous combined hormone replacement therapy on bleeding rates, quality of life and tolerability in postmenopausal women , 2002, BJOG : an international journal of obstetrics and gynaecology.

[25]  Charles Kooperberg,et al.  Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. , 2002, JAMA.

[26]  G. Bachmann,et al.  Relief of Vasomotor Symptoms and Vaginal Atrophy With Lower Doses of Conjugated Equine Estrogens and Medroxyprogesterone Acetate , 2001 .

[27]  H. Burger,et al.  A Prospective Population‐Based Study of Menopausal Symptoms , 2000, Obstetrics and gynecology.

[28]  J Benichou,et al.  Validation studies for models projecting the risk of invasive and total breast cancer incidence. , 1999, Journal of the National Cancer Institute.

[29]  P. Lønning,et al.  Plasma oestrogen fractions in postmenopausal women receiving hormone replacement therapy: influence of route of administration and cigarette smoking. , 1999, The Journal of endocrinology.

[30]  K. Light,et al.  A comparison of the effect of estrogen with or without progesterone on mood and physical symptoms in postmenopausal women. , 1999, Journal of women's health & gender-based medicine.

[31]  S. Yen,et al.  Reproductive Endocrinology: Physiology, Pathophysiology, and Clinical Management , 1999 .

[32]  Susan R. Johnson,et al.  Symptom Relief and Side Effects of Postmenopausal Hormones: Results From the Postmenopausal Estrogen/Progestin Interventions Trial , 1998, Obstetrics and gynecology.

[33]  R. Mansel,et al.  The long-term course of mastalgia , 1998, Journal of the Royal Society of Medicine.

[34]  J. Wolfe,et al.  Mammographic features and breast cancer risk: effects with time, age, and menopause status. , 1995, Journal of the National Cancer Institute.

[35]  C. Redmond,et al.  Base-line quality-of-life assessment in the National Surgical Adjuvant Breast and Bowel Project Breast Cancer Prevention Trial. , 1995, Journal of the National Cancer Institute.

[36]  A. Miller,et al.  Quantitative classification of mammographic densities and breast cancer risk: results from the Canadian National Breast Screening Study. , 1995, Journal of the National Cancer Institute.

[37]  R. Lobo,et al.  Short-term effects of smoking on the pharmacokinetic profiles of micronized estradiol in postmenopausal women. , 1990, American journal of obstetrics and gynecology.

[38]  D. Sommers,et al.  Vitamin E and benign breast disease. , 1990, Surgery.

[39]  C. Christiansen,et al.  Effects of smoking on serum lipoproteins and bone mineral content during postmenopausal hormone replacement therapy. , 1988, American journal of obstetrics and gynecology.

[40]  C. Christiansen,et al.  Cigarette smoking, serum estrogens, and bone loss during hormone-replacement therapy early after menopause. , 1985, The New England journal of medicine.

[41]  T. K. Hunt,et al.  Vitamin E and benign breast "disease": a double-blind, randomized clinical trial. , 1985, Surgery.

[42]  M. Vessey,et al.  Study of symptoms in middle life with special reference to the menopause. , 1980, British medical journal.

[43]  L. Shulman.  Health Outcomes After Stopping Conjugated Equine Estrogens Among Postmenopausal Women With Prior Hysterectomy: A Randomized Controlled Trial , 2011 .

[44]  R. Prentice,et al.  The effects of postmenopausal hormone therapy on serum estrogen, progesterone, and sex hormone-binding globulin levels in healthy postmenopausal women , 2010, Menopause.

[45]  Leon Speroff,et al.  Comprar Clinical gynecologic endocrinology and infertility. 8th Ed | Marc Fritz | 9780781779685 | Lippincott Williams & Wilkins , 2010 .

[46]  J. Hsia,et al.  Physical activity and diabetes risk in postmenopausal women. , 2005, American journal of preventive medicine.

[47]  R. Barbieri,et al.  Yen and Jaffe's reproductive endocrinology : physiology, pathophysiology, and clinical management , 2004 .

[48]  Beth A Reboussin,et al.  Postmenopausal hormone therapy and change in mammographic density. , 2003, Journal of the National Cancer Institute.

[49]  JoAnn E. Manson,et al.  Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group. , 1998, Controlled clinical trials.

[50]  Leon Speroff,et al.  Clinical gynecologic endocrinology and infertility , 1983 .